Oracle is in an accelerating structural downtrend driven by a toxic combination of negative free cash flow through 2029, a planned $40 billion capital raise that will dilute shareholders and stress its investment-grade credit rating, and a 40%+ peak-to-trough decline that has now been confirmed by the formal 10-K filing. At $157.53, the stock has already shed ~$70 billion in market cap yet the core overhang — equity dilution, leverage at 3.4x EBITDA, and multiyear cash burn — remains entirely unresolved, making further downside the path of least resistance over the next 2-3 months. The additional revelation of 21,000 job cuts (13% of workforce) signals that even management acknowledges structural cost pressure in the legacy business, removing a key bull-case offset to margin compression.